Health Economics Expertise RTI Health Solutions' strong expertise in health economics, evident from the recent award received for best research presentation, showcases a potential for collaborations with pharmaceutical companies looking to analyze the economic impact of their products.
Partnership with Regulatory Agencies The collaboration between RTI Health Solutions and the FDA on evaluating COVID-19 vaccine effectiveness signifies an opportunity for partnerships with other regulatory bodies globally, positioning RTI-HS as a trusted research partner in the healthcare industry.
Innovative Research Models Development of innovative three-stage models, like estimating childhood influences on long-term health outcomes, presents a unique selling point for RTI Health Solutions in attracting clients seeking advanced research methodologies for their healthcare studies.
Expanding Research Capabilities RTI Health Solutions' launch of an epidemiological case-control study and the development of Ngene software demonstrate a commitment to expanding research capabilities, offering potential clients cutting-edge tools and comprehensive study designs.
Key Personnel Expertise The hiring of Brett Hauber, a seasoned economist and VP in health preference assessment, as a Senior Fellow enhances RTI Health Solutions' credibility and may appeal to clients looking for expert guidance in health economics and policy evaluation.